Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between the Platelet-Derived Growth Factor/Platelet-Derived Growth Factor Receptor System and Risk of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. | Comput Math Methods Med | 2022 | 35295202 | PubTator, text mining | PubMed |
| Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update. | Brain Pathol | 2022 | 35289001 | PubTator, text mining | PubMed |
| A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL. | J Immunother Cancer | 2022 | 35288466 | PubTator, text mining | PubMed |
| Exploring the ovine sperm transcriptome by RNAseq techniques. I Effect of seasonal conditions on transcripts abundance. | PLoS One | 2022 | 35286314 | PubTator, text mining | PubMed |
| A narrative review of research advances in hypoxic pulmonary hypertension. | Ann Transl Med | 2022 | 35280399 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells and Their Contribution to Angiogenic Processes in Tissue Regeneration. | Int J Mol Sci | 2022 | 35269568 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets. | Cancers (Basel) | 2022 | 35267539 | PubTator, text mining | PubMed |
| Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells. | Cancers (Basel) | 2022 | 35267509 | PubTator, text mining | PubMed |
| Transcriptomic profiling of the telomerase transformed Mesenchymal stromal cells derived adipocytes in response to rosiglitazone. | BMC Genom Data | 2022 | 35264099 | PubTator, text mining | PubMed |
| Fibrous stroma: Driver and passenger in cancer development. | Sci Signal | 2022 | 35258999 | PubTator, text mining | PubMed |
| TraSig: inferring cell-cell interactions from pseudotime ordering of scRNA-Seq data. | Genome Biol | 2022 | 35255944 | PubTator, text mining | PubMed |
| Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers. | J Transl Med | 2022 | 35255925 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy. | Clin Cancer Res | 2022 | 35254400 | PubTator, text mining | PubMed |
| Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. | Front Pediatr | 2022 | 35252060 | PubTator, text mining | PubMed |
| Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors. | Mol Cancer Ther | 2022 | 35247919 | PubTator, text mining | PubMed |
| Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. | Elife | 2022 | 35244537 | PubTator, text mining | PubMed |
| PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle. | Commun Biol | 2022 | 35241778 | PubTator, text mining | PubMed |
| Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons. | Adv Sci (Weinh) | 2022 | 35240008 | PubTator, text mining | PubMed |
| SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease. | Front Immunol | 2022 | 35222400 | PubTator, text mining | PubMed |
| A B-cell or a key player? The different roles of B-cells and antibodies in melanoma. | Pigment Cell Melanoma Res | 2022 | 35218154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=43